Skip to content

Effect of the structured exercise intervention for dementia prevention on cognitive function in patients with mild cognitive impairment

Effect of a 20-week multicomponent and structured exercise intervention on cognitive function in patients with mild cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004619
Enrollment
52
Registered
2020-01-09
Start date
2020-01-20
Completion date
Unknown
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : The non-intervention group will perform the regular walking exercise and will implement the structured multi-domain exercise intervention program in the intervention group. Both groups are 20

Sponsors

Ajou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. One or more of the following dementia risk factors: 1) Hypertension on medication 2) Diabetes mellitus on oral hypoglycemic agent or insulin 3) Dyslipidemia on medication 4) Obesity: BMI 25kg/m2 and above 5) Smoking: patients who have smoked at least 100 cigarettes in their lifetime and smoked more than 1 cigarette in the last month 6) Excessive drinking: more than 170 grams of alcohol per week 7) An educational background of less than 9 years 8) Aerobic exercise with moderate strength (3~6 METS) less than 150 minutes per week (more than 30 minutes, more than 5 days a weak) or high-intensity aerobic exercise (>6METS) less than 60 minutes per week (20 minutes or more, 3 days or more per week) 9) Insufficient strength exercise; do not perform 8 to 10 muscle group exercises for 10 to 15 repetitions per every exercise session for 2 days or more per week 2. No significant daily life dysfunction: KIADL 0.42 or below 3. The participant should not be dementia in the judgement of clinicians. 4. Literacy 5. Written consent to participate in the research

Exclusion criteria

Exclusion criteria: 1. Mental illness such as major depression disorder 2. Dementia 3. Other neurodegenerative diseases such as Parkinson's disease 4. MMSE z-score -1.5 or less 5. Malignant tumors within 5 years of not being cured 6. Revascularization or stent insertion within 1 year 7. Severe or unstable symptomatic cardiovascular disease 8. Any other evidence of serious or unstable physical condition (acute or severe asthma, active gastrointestinal ulcer, severe liver disease or kidney disease enough to receive dialysis), patients with other medical conditions that may interfere with the completion of the clinical trial 9. Severe vision loss, severe hearing loss, or communication impairment beyond which intervention and validation cannot be performed 10. Illiteracy 11. In case it is deemed difficult to participate in the research in cooperation with the researchers' judgment to the end 12. In case of difficulty in safely participating in arbitration programs in the judgment of the researchers 13. Participation in other intervention studies

Design outcomes

Primary

MeasureTime frame
physical activity (muscle strength, balance, flexibility, cardiopulmonary endurance, cooperation);Neuropsychological test for cognitive evaluation;brain imaging (brain MRI for evaluating cortical thickness and activated brain area);Electroencephalogram;Blood biomarker (BDNF, anandamide, 2-arachidonoylglycerol)

Secondary

MeasureTime frame
Emotional state (depression, anger proneness)

Countries

Korea, Republic of

Contacts

Public ContactKyunghwa Sun

Ajou University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026